Although only a very limited number of patients harboring biallelic deleterious variants in TNNT3 have been reported so far, the emerging core clinical phenotype suggests that this congenital myopathy should be considered a discrete entity, with only partial overlap with DA2B2. Here, TNNT3 is linked to congenital myopathy.